Valid

YY/T 0870.3-2013Test for genotoxicity of medical devices - Part 3: In vitro mammalian cell gene mutation test using mouse lymphoma cell (English PDF)

医疗器械遗传毒性试验 第3部分:用小鼠淋巴瘤细胞进行的体外哺乳动物细胞基因突变试验

Preview PDF

This is a limited preview

Buy now to download the full PDF (15 pages)

Need quotation for your management?

Get a formal quotation for YY/T 0870.3-2013 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

October 21, 2013

Implementation date

October 1, 2014

Scope

YY/T 0870.3-2013 is the English-translated version of 医疗器械遗传毒性试验 第3部分:用小鼠淋巴瘤细胞进行的体外哺乳动物细胞基因突变试验.

YY/T 0870.3-2013 is the Chinese standard "Test for genotoxicity of medical devices - Part 3: In vitro mammalian cell gene mutation test using mouse lymphoma cell".

Its scope clause reads: This section of YY/T 0870 specifies the use of the mouse lymphoma cell line (L5178YTK /-3.7.2C) for medical devices/materials. Method for in vitro mammalian cell gene mutation assay.

This section applies to the TK gene mutation test using the mouse lymphoma cell line (L5178YTK /-3.7.2C) using the microplate method. A method of assessing cytotoxicity using both relative survival (RS) and relative total growth (RTG) indicators.

Note 1. In vitro mammalian cell gene mutation test of oral materials can be found in YY/T 0127.17. Note 2. In vitro mammalian cell gene mutation testing of nanomaterials may require specific revisions to the methods in this section, but this section does not give description. Its clauses include terms and definitions.

Found what you need?

Document preview — YY/T 0870.3-2013

National Standard of the People's Republic of China

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • 1 Scope
  • 2 Normative references
  • 3 Terms and definitions
  • 3.1 Cloning efficiency
  • 3.2 Chromosome cleavage agent clastogen
  • 3.3 Forward mutation
  • 3.4 Frameshift mutant
  • 3.5 Mitotic recombination

1 Scope

This section of YY/T 0870 specifies the use of the mouse lymphoma cell line (L5178YTK /-3.7.2C) for medical devices/materials.

Method for in vitro mammalian cell gene mutation assay.

This section applies to the TK gene mutation test using the mouse lymphoma cell line (L5178YTK /-3.7.2C) using the microplate method.

A method of assessing cytotoxicity using both relative survival (RS) and relative total growth (RTG) indicators.

Note 1. In vitro mammalian cell gene mutation test of oral materials can be found in YY/T 0127.17.

Note 2. In vitro mammalian cell gene mutation testing of nanomaterials may require specific revisions to the methods in this section, but this section does not give description.

2 Normative references

The following documents are indispensable for the application of this document. For dated references, only dated versions apply to this article.

Pieces. For undated references, the latest edition (including all amendments) applies to this document.

GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation and testing in the process of risk management

GB/T 16886.3 Biological evaluation of medical devices - Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity

GB/T 16886.12 Biological evaluation of medical devices - Part 12. Sample preparation and reference materials

3 Terms and definitions

The following terms and definitions as defined in GB/T 16886.1, GB/T 16886.3 and GB/T 16886.12 apply to this document.

3.1 Cloning efficiency

Cells seeded at low density grew to a percentage of countable colonies.

3.2 Chromosome cleavage agent clastogen

Any substance that causes aberrations in the chromosome structure of a cell or organism.

3.3 Forward mutation

Transformation from a prototype (wild type) to a mutant gene mutation can cause changes in enzyme activity and encoded proteins.

3.4 Frameshift mutant

A substance that causes an increase or decrease in single or multiple base pairs in a DNA molecule.

3.5 Mitotic recombination

During mitosis, recombination between homologous chromatids may induce DNA double-strand breaks or loss of heterozygosity.

YY/T 0916.7-2024 | YY/T 0841-2023 | YY/T 0916.1-2021 | YY/T 0870.8-2024 | YY/T 0870.7-2023 | YY/T 0870.6-2019 | […]

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.

Similar standards

How to Download YY/T 0870.3-2013

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Fast delivery

    After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
15 pages
Fast delivery
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 0870.3-2013

$165.00